12 Industrials Stocks Moving In Friday’s Pre-Market Session
Gainers Nauticus Robotics (NASDAQ:KITT) shares moved upwards by 23.3% to $0.2 during Friday’s pre-market session. The company’s market…
12 Industrials Stocks Moving In Monday’s After-Market Session
Gainers Ocean Power Techs (AMEX:OPTT) shares rose 37.9% to $0.27 during Monday’s after-market session. The market value of…
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Shares of H&E Equipment Services, Inc. (NASDAQ:HEES) fell sharply during Tuesday’s session following mixed first-quarter results. H&E Equipment…
12 Industrials Stocks Moving In Tuesday’s Intraday Session
Gainers Swvl Hldgs (NASDAQ:SWVL) shares increased by 39.0% to $14.07 during Tuesday’s regular session. The market value of…
12 Industrials Stocks Moving In Thursday’s Pre-Market Session
Gainers Intelligent Living (NASDAQ:ILAG) shares rose 56.6% to $0.85 during Thursday’s pre-market session. The market value of their…
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday’s session after the company reported worse-than-expected quarterly financial results.…
12 Industrials Stocks Moving In Tuesday’s Intraday Session
Gainers Shimmick (NASDAQ:SHIM) stock rose 31.1% to $2.95 during Tuesday’s regular session. The company’s market cap stands at…
HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Nasdaq Composite gaining over 200 points on Tuesday. Shares of HealthStream, Inc.…
12 Industrials Stocks Moving In Tuesday’s Pre-Market Session
Gainers Pineapple Energy (NASDAQ:PEGY) shares increased by 46.3% to $0.07 during Tuesday’s pre-market session. The company’s market cap…
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.